Jeff Wisotzkey, Ph.D., HCLC, CC
Clinical Laboratory Director,
Jeff Wisotzkey has more than 25 years of experience leading strategic, scientific and laboratory operations in various clinical settings. Currently, the development of HNL’s precision medicine program and expansion of genetics services is Wisotzkey’s primary focus; however, as HNL’s Clinical Laboratory Director and Scientific Officer, he is also responsible for leadership and oversight in the areas of Chemistry/Immunochemistry, Flow Cytometry, Microbiology, Forensic DNA analysis, Cytogenetics and Toxicology.
Prior to joining HNL, Jeff was most recently Laboratory Director and Vice President of Molecular Pathology at Genomind. In that role he was responsible for the creation, development and operation of a pharmacogenetic testing laboratory focused on genetic diagnostics in neuropsychiatry. Prior to that, Wisotzkey served as the Director of Molecular Pathology and Technical Director of Laboratory Operations for the Central PA Alliance Laboratory (CPAL). He oversaw referred testing from six regional health systems, providing a suite of services including full service Blood Donor Testing, Chemistry/Immunochemistry, Flow Cytometry, FISH and Molecular Diagnostics.
Jeff has also served as Technical Director of the Molecular Diagnostics and Research Laboratory at York Hospital where he created and directed the Molecular Diagnostics Laboratory, one of the first molecular labs in the nation to be established in a community-based teaching hospital. Wisotzkey received his doctoral degree from the University of Houston in molecular biology, and he completed postdoctoral training at Pennsylvania State University’s Hershey Medical Center. He is a board certified High Complexity Laboratory Director (HCLD) and Clinical Consultant (CC).